000			01660na a2200289 4500
003			H12O
005			20210625062758.0
008			130622s2012 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_91893 _aAndrés Esteban, Eva _eInstituto de Investigación i+12
100			_aBarcena García, Carmen _92081 _eAnatomía Patológica
100			_aCiruelos Gil, Eva María _91082 _eOncología Médica
100			_aCortés-Funes Castro, Hernán _91181 _eOncología Médica
245	0	0	_aBehaviour of breast cancer molecular subtypes through tumour progression. _h[artículo]
260			_bClinical & Translational Oncology, _c2012
300			_a14(6):481-5.
500			_aFormato Vancouver: Castañeda CA, Andrés E, Barcena C, Gómez HL, Cortés-Funés H, Ciruelos E. Behaviour of breast cancer molecular subtypes through tumour progression. Clin Transl Oncol. 2012 Jun;14(6):481-5.
501			_aPMID: 22634538
504			_aContiene 25 referencias
520			_aINTRODUCTION Breast cancer (BC) becomes more aggressive throughout disease progression. Clinical stage is correlated with patient outcome. We hypothesised that BC molecular subtypes are associated with a poor prognosis in advanced clinical stages. We analysed the distribution and behaviour of molecular subtypes at different BC tumour size and variation of molecular subtype in recurrent lesions.
710			_9303 _aServicio de Oncología Médica
710			_9625 _aInstituto de Investigación imas12
710			_9330 _aServicio de Anatomía Patológica
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/2/pc2583.pdf _ySolicitar documento
942			_n0 _2ddc _cART
999			_c2583 _d2583